Tarsus Pharmaceuticals Inc (TARS)
Cost of Revenue
$12.11M
Quarterly · Period ending: · USD
TARS Cost of Revenue
Latest reported$12.11Mperiod ending
Latest reported$12.11Mperiod ending
TARS Quarterly Cost of Revenue ($0.00 → $12.11M)
Quarterly cost of revenue
High-resolution chart · PNG
TARS cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 12,113,000 | |
| 9,396,000 | |
| 10,927,000 | |
| 24,593,000 | |
| 6,237,000 | |
| 5,211,000 | |
| 4,926,000 | |
| 3,242,000 | |
| 3,004,000 | |
| 1,654,000 | |
| 1,216,000 | |
| 377,000 | |
| 316,000 | |
| 255,000 | |
| 400,000 | |
| 211,000 | |
| 522,000 | |
| 33,000 | |
| -24,000 | |
| 65,000 | |
| 737,000 | |
| 1,297,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 20,000 | |
| 0 | |
| 0 |